Tina S. Morris

Tina S. Morris

Auto-generated profile, based on publicly available information

Tina S. Morris

Biologics and Biotechnology Department, US Pharmacopeia, Rockville, Maryland, USA

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2000 in Pharmacogenomics
Verified
Journal Article
Closed access
SWScot R Weinberger
Scot R Weinberger
TMTina S Morris
Tina S Morris
MPMichael Pawlak
Michael Pawlak
This article presents current trends and advances in protein biochip technologies that rely upon extraction and retention of target proteins from liquid media. Analytical strengths as well as technical challenges for these evolving platforms are presented with particular emphasis on selectivity, sensitivity, throughput and utility in the post-genome era. A general review of protein biochip technology is provided, which delineates approaches for protein biochip format and operation, as well as protein detection. A focused discussion of three protein biochip technologies, Biomolecular Interaction Analysis (Biacore, Uppsala, Sweden), Surface Enhanced Laser Desorption/Ionisation (SELDI) ProteinChip Arrays (Ciphergen Biosystems, Fremont, CA, USA) and Fluorescent Planar Wave Guide (Zeptosens, Witterswil, Switzerland), follows along with examples of relevant applications.

1 February 2000 in The Journal of Immunology
Verified
Journal Article
Closed access
RNRobert J B Nibbs
Robert J B Nibbs
TSTheodora W Salcedo
Theodora W Salcedo
JCJohn D M Campbell
John D M Campbell
XYXiao-Tao Yao
Xiao-Tao Yao
YLYuling Li
Yuling Li
GGGerard J Graham
Gerard J Graham
Allergic reactions are characterized by the infiltration of tissues by activated eosinophils, Th2 lymphocytes, and basophils. The β-chemokine receptor CCR3, which recognizes the ligands eotaxin, eotaxin-2, monocyte chemotactic protein (MCP) 3, MCP4, and RANTES, plays a central role in this process, and antagonists to this receptor could have potential therapeutic use in the treatment of allergy. We describe here a potent and specific CCR3 antagonist, called Met-chemokine β 7 (Ckβ7), that prevents signaling through this receptor and, at concentrations as low as 1 nM, can block eosinophil chemotaxis induced by the most potent CCR3 ligands. Met-Ckβ7 is a more potent CCR3 antagonist than Met- and aminooxypentane (AOP)-RANTES and, unlike these proteins, exhibits no partial agonist activity and is highly specific for CCR3. Thus, this antagonist may be of use in ameliorating leukocyte infiltration associated with allergic inflammation. Met-Ckβ7 is a modified form of the β-chemokine macrophage inflammatory protein (MIP) 4 (alternatively called pulmonary and activation-regulated chemokine (PARC), alternative macrophage activation-associated C-C chemokine (AMAC) 1, or dendritic cell-derived C-C chemokine (DCCK) 1). Surprisingly, the unmodified MIP4 protein, which is known to act as a T cell chemoattractant, also exhibits this CCR3 antagonistic activity, although to a lesser extent than Met-Ckβ7, but to a level that may be of physiological relevance. MIP4 may therefore use chemokine receptor agonism and antagonism to control leukocyte movement in vivo. The enhanced activity of Met-Ckβ7 is due to the alteration of the extreme N-terminal residue from an alanine to a methionine.

9 June 2016 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
ASAnita Y Szajek
Anita Y Szajek
ECEdward Chess
Edward Chess
KJKristian Johansen
Kristian Johansen
GGGyöngyi Gratzl
Gyöngyi Gratzl
EGElaine Gray
Elaine Gray
AAAli Al-Hakim
Ali Al-Hakim

25 February 2002 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
DODeena A. Oren
Deena A. Oren
YLYuling Li
Yuling Li
YVYulia Volovik
Yulia Volovik
TMTina S. Morris
Tina S. Morris
CDChhaya Dharia
Chhaya Dharia
EAEddy Arnold
Eddy Arnold

1 May 1997 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
TMTina S Morris
Tina S Morris
SFSven Frormann
Sven Frormann
SSShirley Shechosky
Shirley Shechosky
CLChristopher Lowe
Christopher Lowe
MLManjinder S Lall
Manjinder S Lall
BMBruce A Malcolm
Bruce A Malcolm

24 June 2014 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
BMBarbara Mulloy
Barbara Mulloy
AHAlan Heath
Alan Heath
ZSZachary Shriver
Zachary Shriver
FJFabian Jameison
Fabian Jameison
AHAli Al Hakim
Ali Al Hakim
ASAnita Y. Szajek
Anita Y. Szajek